Series date: 
07/01/2020 - 7:00am CDT to 06/30/2021 - 4:00pm CDT
Location

Please check the individual session for location or broadcast availability.  

Frequency

Weekly

Series Director

Terzah Horton, MD, PhD

Target Audience and Needs

Clinical and research faculty, graduate and medical students, clinical and postdoctoral fellows, and research nurses in pediatric hematology-oncology need to be regularly updated on the latest data from clinical trials in pediatric patients with hematological-oncological disorders, on the advances in the development of targeted therapies, on the developments in ethical/legal issues related to end of life care, and on the new practice standards for follow-up care for long-term survivors. The series aims to increase knowledge and skills of the learners in these topic areas in order to enhance the quality of care, increase patient safety, and improve patient outcomes.

Educational Methods

Educational methods will include lectures, case presentations, literature review, and panel discussion.

Objectives

At the conclusion of the sessions, the participants should be able to:

  • Discuss new research data in pediatric hematologic and oncologic disorders and incorporate these data into clinical and research activities.
  • Identify ethical and legal issues pertaining to clinical care and research activities pertaining to pediatric hematology and oncology.
  • Evaluate drug development in pediatric cancers and blood disorders.
  • Analyze and interpret the significance of long-term survivorship issues in pediatric cancer and hematologic disorders.
  • Develop an understanding of how QI cycles can be applied to a specific and common clinical problem.
  • Learn how to improve communication between clinical teams in different medical settings.
Evaluation

Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator 

Edrea Gonzales
Edrea.Gonzales@bcm.edu
832-824-4841

Series location: 
Texas Children's Hospital
6621 Fannin Street
Houston, TX 77030
United States
See map: Google Maps

Sessions

Session Date
Improving Access to Care in Sickle Cell Disease 04/15/2021 - 8:00am to 9:00am CDT
Novel Immunotherapy Approaches for Neuroblastoma 04/29/2021 - 8:00am to 9:00am CDT
Chimeric Antigen Receptor T Cells: Beyond CD19 05/06/2021 - 8:00am to 9:00am CDT
Bridging the Disparity Gap for Burkitt Lymphoma in Africa 05/27/2021 - 8:00am to 9:00am CDT
The Role of GALNT14 in Chemotherapy Resistance and Metastasis in Pediatric Osteosarcoma/Probing the Requirement of Canonical NF-kB Activity in C11ORF95-RELA Ependymoma 06/03/2021 - 8:00am to 9:00am CDT
Of Meis and Menin: Targeting NUP98-Fusion Proteins in Acute Myeloid Leukemia/Enhancing Tumor-Directed T-Cells through Forced Expression of CD27 06/10/2021 - 8:00am to 9:00am CDT
Pediatric Rhabdomyosarcoma in the United States: An Epidemiological Review/The Impact of Texas-Mexico Border Residence on Childhood Leukemia Survival 06/17/2021 - 8:00am to 9:00am CDT
A High-Throughput CAR Library Screen for Improving Neuroblastoma Immunotherapy/Reducing Intravenous Immunoglobulin Adverse Drug Events in Children with Immune Thrombocytopenia: A Feasibility Study of Post-IVIG Prophylactic Medication 06/24/2021 - 8:00am to 9:00am CDT

Pages